Overexpression of NPC1L1 in the livers of transgenic Bama miniature pigs accelerates lipid peroxidation
详细信息 查看全文
- 作者：Chongli Xu (1) (2)
Yu Liu (3)
Yuchen Gong (4)
Xinping Duan (1)
Xiaochun Tang (1)
Mingjun Zhang (1)
Daxin Pang (1)
Liqing Yu (5)
Hong Wei (3)
Hongsheng Ouyang (1)
1. Jilin Provincial Key Laboratory of Animal Embryo Engineering ; College of Animal Sciences ; Jilin University ; 5333 Xi An DaLu ; Changchun ; 130062 ; People鈥檚 Republic of China
2. College of Chemical Engineering and Biotechnology ; Jilin Institute of Chemical Technology ; 45 ChengDe Road ; Jilin ; 132022 ; People鈥檚 Republic of China
3. Department of Laboratory Animal Science ; College of Basic Medicine ; Third Military Medical University ; Chongqing ; 400038 ; People鈥檚 Republic of China
4. College of Animal Science ; Jilin Agricultural University ; Changchun ; 130118 ; People鈥檚 Republic of China
5. Department of Animal and Avian Sciences ; University of Maryland ; College Park ; 20742 ; Maryland ; USA - 关键词：Niemann ; Pick C1 Like 1 (NPC1L1) ; Overexpression ; Nuclear transfer ; Transcription ; Lipid peroxidation
- 刊名：Genes & Genomics
- 出版年：2015
- 出版时间：February 2015
- 年：2015
- 卷：37
- 期：2
- 页码：183-191
- 全文大小：1,105 KB
- 参考文献：1. Al-Rawi NH (2011) Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res 8:22鈥?8 243" target="_blank" title="It opens in new window">CrossRef
2. Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M et al (2004) Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 303:1201鈥?204 26/science.1093131" target="_blank" title="It opens in new window">CrossRef
3. Anzenbacherov谩 E, Anzenbacher P, Svoboda Z, Ulrichov谩 J, Kvetina J, Zoulov谩 J, Perl铆k F, Mart铆nkov谩 J (2003) Minipig as a model for drug metabolism in man: comparison of in vitro and in vivo metabolism of propafenone. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147:155鈥?59 2003.021" target="_blank" title="It opens in new window">CrossRef
4. Assady M, Farahnak A, Golestani A, Esharghian M (2011) Superoxide dismutase (SOD) enzyme activity assay in fasciola spp. parasites and liver tissue extract. Iran J Parasitol 6:17鈥?2
5. Assy N, Grozovski M, Bersudsky I, Szvalb S, Hussein O (2006) Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease. World J Gastroenterol 12:4369鈥?376
6. Basaranoglu M, Basaranoglu G, Sent眉rk H (2013) From fatty liver to fibrosis: a tale of 鈥渟econd hit鈥? World J Gastroenterol 19:1158鈥?165 CrossRef
7. Bobard A, Hainault I, Ferr茅 P, Foufelle F, Bossard P (2005) Differential regulation of sterol regulatory element-binding protein 1c transcriptional activity by insulin and liver X receptor during liver development. J Biol Chem 280:199鈥?06 22200" target="_blank" title="It opens in new window">CrossRef
8. Catal谩 A (2012) Lipid peroxidation modifies the picture of membranes from the 鈥淔luid Mosaic Model鈥?to the 鈥淟ipid Whisker Model鈥? Biochimie 94:101鈥?09 2011.09.025" target="_blank" title="It opens in new window">CrossRef
9. Chan J, Kushwaha RS, Vandeberg JF, Vandeberg JL (2008) Effect of ezetimibe on plasma cholesterol levels, cholesterol absorption, and secretion of biliary cholesterol in laboratory opossums with high and low responses to dietary cholesterol. Metabolism 57:1645鈥?654 2008.07.019" target="_blank" title="It opens in new window">CrossRef
10. Chen J, Jiang Y, Ma KY, Chen F, Chen ZY (2011) Microalga decreases plasma cholesterol by down-regulation of intestinal NPC1L1, hepatic LDL receptor, and HMG-CoA reductase. J Agric Food Chem 59:6790鈥?797 21/jf200757h" target="_blank" title="It opens in new window">CrossRef
11. Davies JP, Scott C, Oishi K, Liapis A, Ioannou Y (2005) Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J Biol Chem 280:12710鈥?2720 200" target="_blank" title="It opens in new window">CrossRef
12. Davis HR Jr, Altmann SW (2009) Niemann-Pick C1 like 1 (NPC1L1) an intestinal sterol transporter. Biochim Biophys Acta 1791:679鈥?83 2009.01.002" target="_blank" title="It opens in new window">CrossRef
13. Davis HR Jr, Hoos LM, Tetzloff G, Maguire M, Zhu LJ, Graziano MP, Altmann SW (2007) Deficiency of Niemann-Pick C1 like 1 prevents atherosclerosis in / apoE鈭?鈭?mice. Arterioscler Thromb Vasc Biol 27:841鈥?49 257627.40486.46" target="_blank" title="It opens in new window">CrossRef
14. Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M, Ishii H, Yoshida M (2007) Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett 581:5664鈥?670 2007.11.023" target="_blank" title="It opens in new window">CrossRef
15. Diraison F, Parton L, Ferr茅 P, Foufelle F, Briscoe CP, Leclerc I, Rutter GA (2004) Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem J 378:769鈥?78 2/BJ20031277" target="_blank" title="It opens in new window">CrossRef
16. Engelking LJ, Kuriyama H, Hammer RE, Horton JD, Brown MS, Goldstein JL, Liang G (2004) Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Investig 113:1168鈥?175 2/JCI20978" target="_blank" title="It opens in new window">CrossRef
17. Enjoji M, Machida K, Kohjima M, Kato M, Kotoh K, Matsunaga K, Nakashima M, Nakamuta M (2010) NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. Lipids Health Dis 9:29 29" target="_blank" title="It opens in new window">CrossRef
18. Feldstein AE, Lopez R, Tamimi TA, Yerian L, Chung YM, Berk M, Zhang R, McIntyre TM, Hazen SL (2010) Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Lipid Res 51:3046鈥?054 CrossRef
19. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR Jr, Dean DC, Detmers PA et al (2005) The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 102:8132鈥?137 269102" target="_blank" title="It opens in new window">CrossRef
20. Griffin MJ, Sul HS (2004) Insulin regulation of fatty acid synthase gene transcription: roles of USF and SREBP-1c. IUBMB Life 56:595鈥?00 216540400022474" target="_blank" title="It opens in new window">CrossRef
21. Gulec B, Coskun K, Yigitler C, Yigit T, Aydin A, Oner K (2008) Ischemia-reperfusion injury in the liver during renal transplantation: does perfusion solution play any role? Transplant Proc 40:59鈥?2 2007.11.023" target="_blank" title="It opens in new window">CrossRef
22. Ikeda S, Miyazaki H, Nakatani T, Kai Y, Kamei Y, Miura S, Tsuboyama-Kasaoka N, Ezaki O (2002) Up-regulation of SREBP-1c and lipogenic genes in skeletal muscles after exercise training. Biochem Biophys Res Commun 296:395鈥?00 291X(02)00883-5" target="_blank" title="It opens in new window">CrossRef
23. Jia L, Betters JL, Yu L (2011) Niemann-Pick C1-Like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu Rev Physiol 73:239鈥?59 2110-142233" target="_blank" title="It opens in new window">CrossRef
24. Joyce CW, Wagner EM, Basso F, Amar MJ, Freeman LA, Shamburek RD, Knapper CL, Syed J, Wu J, Vaisman BL et al (2006) ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis. J Biol Chem 281:33053鈥?3065 26200" target="_blank" title="It opens in new window">CrossRef
25. Labont茅 ED, Camarota LM, Rojas JC, Jandacek RJ, Gilham DE, Davies JP, Ioannou YA, Tso P, Hui DY, Howles PN (2008) Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1鈭?鈭?mice. Am J Physiol Gastrointest Liver Physiol 295:G776鈥揋783 2/ajpgi.90275.2008" target="_blank" title="It opens in new window">CrossRef
26. Lai L, Prather RS (2003) Production of cloned pigs by using somatic cells as donors. Cloning Stem Cells 5:233鈥?41 23003772032754" target="_blank" title="It opens in new window">CrossRef
27. Leamy AK, Egnatchik RA, Young JD (2013) Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 52:165鈥?74 2012.10.004" target="_blank" title="It opens in new window">CrossRef
28. Leonarduzzi G, Arkan MC, Ba艧a臒a H, Chiarpotto E, Sevanian A, Poli G (2000) Lipid oxidation products in cell signaling. Free Radic Biol Med 28:1370鈥?378 216-1" target="_blank" title="It opens in new window">CrossRef
29. Levent G, Ali A, Ahmet A, Polat EC, Aytac C, Ayse E, Ahmet S (2006) Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J Transl Med 4:25 25" target="_blank" title="It opens in new window">CrossRef
30. Liu Y, Wang Z, Yin W, Li Q, Cai M, Zhang C, Xiao J, Hou H, Li H, Zu X (2007) Severe insulin resistance and moderate glomerulosclerosis in a minipig model induced by high-fat/high-sucrose/high-cholesterol diet. Exp Anim 56:11鈥?0 CrossRef
31. Liu Y, Zeng BH, Shang HT, Cen YY, Wei H (2008) Bama miniature pigs (Sus scrofa domestica) as a model for drug evaluation for humans: comparison of in vitro metabolism and in vivo pharmacokinetics of lovastatin. Comp Med 58:580鈥?87
32. Liu HB, Lv PR, He RG, Yang XG, Qin XE, Pan TB, Huang GY, Huang MR, Lu YQ, Lu SS et al (2010) Cloned Guangxi Bama minipig and its offspring have normal reproductive performance. Cell Reprogram 12:543鈥?50 2009.0094" target="_blank" title="It opens in new window">CrossRef
33. Miura S, Saku K (2008) Ezetimibe, a selective inhibitor of the transport of cholesterol. Intern Med 47:1165鈥?170 2169/internalmedicine.47.1099" target="_blank" title="It opens in new window">CrossRef
34. Musso G, Gambino R, Cassader M (2010) Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev 11:430鈥?45 2009.00657.x" target="_blank" title="It opens in new window">CrossRef
35. Nam TG (2011) Lipid peroxidation and its toxicological implications. Toxicol Res 27:1鈥? 2011.27.1.001" target="_blank" title="It opens in new window">CrossRef
36. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T et al (2010) Pathological aspects of lipid peroxidation. Free Radic Res 44:1125鈥?171 2.2010.498478" target="_blank" title="It opens in new window">CrossRef
37. Nomura M, Ishii H, Kawakami A, Yoshida M (2009) Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance. Am J Physiol Endocrinol Metab 297:E1030鈥揈1038 2/ajpendo.00343.2009" target="_blank" title="It opens in new window">CrossRef
38. Poli G, Schaur RJ, Siems WG, Leonarduzzi G (2008) 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 28:569鈥?31 2/med.20117" target="_blank" title="It opens in new window">CrossRef
39. Raghavan S, Subramaniyam G, Shanmugam N (2012) Proinflammatory effects of malondialdehyde in lymphocytes. J Leukoc Biol 92:1055鈥?067 211617" target="_blank" title="It opens in new window">CrossRef
40. San茅 AT, Sinnett D, Delvin E, Bendayan M, Marcil V, M茅nard D, Beaulieu JF, Levy E (2006) Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res 47:2112鈥?120 200" target="_blank" title="It opens in new window">CrossRef
41. Santos JC, Valentim IB, de Ara煤jo OR, Ataide TR, Goulart MO (2013) Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products. Int J Mol Sci 14:19846鈥?9866 CrossRef
42. Sato Y, Suzuki R, Kobayashi M, Itagaki S, Hirano T, Noda T, Mizuno S, Sugawara M, Iseki K (2012) Involvement of cholesterol membrane transporter Niemann-Pick C1-like 1 in the intestinal absorption of lutein. J Pharm Pharm Sci 15:256鈥?64
43. Shimano H (2000) Sterol regulatory element-binding protein-1 as a dominant transcription factor for gene regulation of lipogenic enzymes in the liver. Trends Cardiovasc Med 10:275鈥?78 CrossRef
44. Shimano H (2001) Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40:439鈥?52 27(01)00010-8" target="_blank" title="It opens in new window">CrossRef
45. Shimano H (2002) Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitam Horm 65:167鈥?94 29(02)65064-2" target="_blank" title="It opens in new window">CrossRef
46. Spirlandeli AL, Deminice R, Jordao AA (2014) Plasma malondialdehyde as biomarker of lipid peroxidation: effects of acute exercise. Int J Sports Med 35:14鈥?8
47. Subramanian S, Goodspeed L, Wang S, Kim J, Zeng L, Ioannou GN, Haigh WG, Yeh MM, Kowdley KV, O鈥橞rien KD, Pennathur S, Chait A (2011) Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J Lipid Res 52:1626鈥?635 246" target="_blank" title="It opens in new window">CrossRef
48. Sun Y, Jiang Q, Tian DY, Lin H, Li H, Han QY, Han W, Si CD, Hu SP et al (2011) Experimental infection of Bama miniature pigs with a highly virulent classical swine fever virus. Virol J 8:452 22X-8-452" target="_blank" title="It opens in new window">CrossRef
49. Surapneni KM, Chandrasada Gopan VS (2008) Lipid peroxidation and antioxidant status in patients with rheumatoid arthritis. Indian J Clin Biochem 23:41鈥?4 2291-008-0010-x" target="_blank" title="It opens in new window">CrossRef
50. Suryawanshi NP, Bhutey AK, Nagdeote AN, Jadhav AA, Manoorkar GS (2006) Study of lipid peroxide and lipid profile in diabetes mellitus. Indian J Clin Biochem 21:126鈥?30 2913080" target="_blank" title="It opens in new window">CrossRef
51. Takaki A, Kawai D, Yamamoto K (2013) Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci 14:20704鈥?0728 20704" target="_blank" title="It opens in new window">CrossRef
52. Tang W, Ma Y, Jia L, Ioannou YA, Davies JP, Yu L (2009) Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8. J Lipid Res 50:293鈥?00 200" target="_blank" title="It opens in new window">CrossRef
53. Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, Ioannou YA, Davies JP, Nilsson LM, Yu L (2007) Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Investig 117:1968鈥?978 2/JCI30060" target="_blank" title="It opens in new window">CrossRef
54. Valasek MA, Repa JJ, Quan G, Dietschy JM, Turley SD (2008) Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters. Am J Physiol Gastrointest Liver Physiol 295:G813鈥揋822 2/ajpgi.90372.2008" target="_blank" title="It opens in new window">CrossRef
55. Vik-Mo AO, Fern酶 J, Skrede S, Steen VM (2009) Psychotropic drugs up-regulate the expression of cholesterol transport proteins including / apoE in cultured human CNS- and liver cells. BMC Pharmacol 9:10 2210-9-10" target="_blank" title="It opens in new window">CrossRef
56. Vodicka P, Smetana K Jr, Dvor谩nkov谩 B, Emerick T, Xu YZ, Ourednik J, Ourednik V, Motl铆k J (2005) The miniature pig as an animal model in biomedical research. Ann N Y Acad Sci 1049:161鈥?71 CrossRef
57. Wang S, Liu Y, Fang D, Shi S (2007) The miniature pig: a useful large animal model for dental and orofacial research. Oral Dis 13:530鈥?37 25.2006.01337.x" target="_blank" title="It opens in new window">CrossRef
58. Wang X, Sugimoto K, Fujisawa T, Shindo N, Minato S, Kamada Y, Hamano M, Ohishi M, Ikegami H, Rakugi H (2014) Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in fatty liver Shionogi mouse. Hepatol Res 44:102鈥?13 2092" target="_blank" title="It opens in new window">CrossRef
59. Wong-Ekkabut J, Xu Z, Triampo W, Tang IM, Tieleman DP, Monticelli L (2007) Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. Biophys J 93:4225鈥?236 29/biophysj.107.112565" target="_blank" title="It opens in new window">CrossRef
60. Yamagishi S, Nakamura K, Matsui T, Sato T, Takeuchi M (2006) Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver. Med Hypotheses 66:844鈥?46 2005.08.022" target="_blank" title="It opens in new window">CrossRef
61. Yang SJ, Choi JM, Kim L, Kim BJ, Sohn JH, Kim WJ, Park SE, Rhee EJ, Lee WY, Oh KW et al (2011) Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes. Biochem Biophys Res Commun 407:153鈥?57 2011.02.129" target="_blank" title="It opens in new window">CrossRef
62. Yang ZH, Miyahara H, Takeo J, Katayama M (2012) Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice. Diabetol Metab Syndr 4:32 2" target="_blank" title="It opens in new window">CrossRef
63. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH (2002a) Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 99:16237鈥?6242 252582399" target="_blank" title="It opens in new window">CrossRef
64. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH (2002b) Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Investig 110:671鈥?80 2/JCI0216001" target="_blank" title="It opens in new window">CrossRef
65. Yu L, Bharadwaj S, Brown JM, Ma Y, Du W, Davis MA, Michaely P, Liu P, Willingham MC, Rudel LL (2006) Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem 281:6616鈥?624 23200" target="_blank" title="It opens in new window">CrossRef - 刊物主题：Microbial Genetics and Genomics; Plant Genetics & Genomics; Animal Genetics and Genomics; Human Genetics;
- 出版者：Springer Netherlands
- ISSN：2092-9293
文摘
Although Niemann-Pick C1-Like 1 (NPC1L1) plays a key role in intestinal cholesterol absorption, regulating cholesterol metabolism and maintaining cholesterol metabolic homeostasis, the molecular mechanism of NPC1L1 in lipid-metabolism disorders leading to liver disease remains largely unknown. Previous studies have shown that NPC1L1 is related with the development of fatty liver. Therefore, we hypothesized that NPC1L1 plays an important role in lipid-metabolism disorders and liver disease by affecting the transcription of certain genes involved in lipid synthesis. To further elucidate the function of NPC1L1, especially in the liver, we used somatic-cell nuclear transfer to establish transgenic pigs that expressed human NPC1L1 in their livers. We investigated superoxide dismutase activities and the levels of free fatty acids and malondialdehyde, a biomarker of lipid peroxidation. Superoxide dismutase activities significantly decreased, and free fatty acid and malondialdehyde levels significantly increased in the NPC1L1 transgenic pigs, indicating that the overexpression of NPC1L1 in the liver resulted in severe lipid peroxidation. Our findings suggest that NPC1L1 plays an important role in lipid-metabolism disorders and liver disease.